rivastigmine has been researched along with Hyperhomocysteinemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Coutinho-Silva, R; Dos Santos, TM; Leite-Aguiar, R; Ramires Junior, OV; Savio, LEB; Silveira, JS; Wyse, ATS | 1 |
Barone, P; Burn, DJ; Hsu, C; Lane, RM; Poewe, W; van Laar, T | 1 |
Ballard, C; Emre, M; He, Y; Lane, R; Leverenz, JB; Morris, C | 1 |
1 trial(s) available for rivastigmine and Hyperhomocysteinemia
Article | Year |
---|---|
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients.
Topics: Aged; Analysis of Variance; Dementia; Double-Blind Method; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Mental Status Schedule; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index | 2008 |
2 other study(ies) available for rivastigmine and Hyperhomocysteinemia
Article | Year |
---|---|
Rivastigmine Reverses the Decrease in Synapsin and Memory Caused by Homocysteine: Is There Relation to Inflammation?
Topics: Acetylcholinesterase; Animals; Homocysteine; Hyperhomocysteinemia; Ibuprofen; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Rivastigmine; Synapsins | 2022 |
BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline.
Topics: Aged; Apolipoprotein E4; Butyrylcholinesterase; Cognition Disorders; Female; Gene Frequency; Genotype; Humans; Hyperhomocysteinemia; Lewy Body Disease; Male; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Psychomotor Disorders; Randomized Controlled Trials as Topic; Rivastigmine; Severity of Illness Index | 2009 |